Nerve stimulation device company ElectroCore files for a $75 million IPO

Shutterstock photo

ElectroCore, which is commercializing a non-invasive nerve stimulation device for treating migraines, filed on Monday with the SEC to raise up to $75 million in an initial public offering.

The Basking Ridge, NJ-based company was founded in 2005 and booked $1 million in sales for the 12 months ended March 31, 2018. It plans to list on the Nasdaq under the symbol ECOR. ElectroCore filed confidentially on February 13, 2018. Piper Jaffray and Evercore ISI are the joint bookrunners on the deal. No pricing terms were disclosed.

The article Nerve stimulation device company ElectroCore files for a $75 million IPO originally appeared on IPO investment manager Renaissance Capital's web site renaissancecapital.com.

Investment Disclosure: The information and opinions expressed herein were prepared by Renaissance Capital's research analysts and do not constitute an offer to buy or sell any security. Renaissance Capital's Renaissance IPO ETF (symbol: IPO) , Renaissance International ETF (symbol: IPOS) , or separately managed institutional accounts may have investments in securities of companies mentioned.

The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.

This article appears in: News Headlines , IPOs

More from Renaissance Capital


Renaissance Capital

Renaissance Capital


Research Brokers before you trade

Want to trade FX?